These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1126780)

  • 21. Psoralen-UVA-treated psoriatic lesions. Ultrastructural changes.
    Hashimoto K; Kohda H; Kumakiri M; Blender SL; Willis I
    Arch Dermatol; 1978 May; 114(5):711-22. PubMed ID: 646392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modified Thiersch grafting in stable vitiligo.
    Bose SK
    J Dermatol; 1996 May; 23(5):362-4. PubMed ID: 8675830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psoralene and melanogenesis in relation to vitiligo.
    Chakraborty DP; Choudhury SK; Dey RN
    Clin Chim Acta; 1976 Oct; 72(2):219-22. PubMed ID: 824075
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prospects of the use of preparations of the psoralen group in the treatment of vitiligo patients].
    Zheltakov MM; Vinokurov IN
    Sov Med; 1966 Aug; 29(8):110-5. PubMed ID: 5991379
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of tacrolimus (FK506) 0.1% ointment WW in vitiligo in children and imperatives of combine therapy with Trioxsalen and Silymarin suspension in progressive vitiligo.
    Sehgal VN
    J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1218-9. PubMed ID: 19192018
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of vitiligo with topical trimethylpsoralen and sunlight.
    Africk J; Fulton J
    Br J Dermatol; 1971 Feb; 84(2):151-6. PubMed ID: 5548464
    [No Abstract]   [Full Text] [Related]  

  • 27. [VITILIGO TREATED WITH PSORALEN DERIVATIVES].
    STRANGE HA
    Ugeskr Laeger; 1964 Jun; 126():860-4. PubMed ID: 14170246
    [No Abstract]   [Full Text] [Related]  

  • 28. Psoralen-deoxyribonucleic acid photoreaction. Characterization of the monoaddition products from 8-methoxypsoralen and 4,5'8-trimethylpsoralen.
    Kanne D; Straub K; Rapoport H; Hearst JE
    Biochemistry; 1982 Mar; 21(5):861-71. PubMed ID: 7074056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psoralen photoallergy caused by plant contact.
    Ljunggren B
    Contact Dermatitis; 1977 Apr; 3(2):85-90. PubMed ID: 872579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and characterization of new psoralen derivatives with superior photoreactivity with DNA and RNA.
    Isaacs ST; Shen CK; Hearst JE; Rapoport H
    Biochemistry; 1977 Mar; 16(6):1058-64. PubMed ID: 849407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical and morphological study of the skin in patients with vitiligo during treatment with psoralen].
    Arutiunov VIa; Arkhangel'skaia NV; Uzhvieva NV
    Vestn Dermatol Venerol; 1972 Feb; 46(2):8-12. PubMed ID: 5036805
    [No Abstract]   [Full Text] [Related]  

  • 32. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
    Bhatnagar A; Kanwar AJ; Parsad D; De D
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro crosslinking of DNA by 8-methoxypsoralen visualized by electron microscopy.
    Bohr V; Lerche A
    Biochim Biophys Acta; 1978 Jul; 519(2):356-64. PubMed ID: 667070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Histochemical changes in the skin of patients with vitiligo during treatment with Psoralen].
    Abdullakhodzhaeva MS; Abidov MM
    Vestn Dermatol Venerol; 1968 Jan; 42(1):24-6. PubMed ID: 5741206
    [No Abstract]   [Full Text] [Related]  

  • 35. Photo(chemo)therapy for vitiligo.
    Pacifico A; Leone G
    Photodermatol Photoimmunol Photomed; 2011 Oct; 27(5):261-77. PubMed ID: 21950634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inactivation of human liver cytochrome P-450 by the drug methoxsalen and other psoralen derivatives.
    Tinel M; Belghiti J; Descatoire V; Amouyal G; Letteron P; Geneve J; Larrey D; Pessayre D
    Biochem Pharmacol; 1987 Mar; 36(6):951-5. PubMed ID: 3494453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of UV-B erythema of psoralen, trimethylpsoralen, and 8 methoxypsoralen.
    Coupez L; Agache PG; Petigny M
    Acta Derm Venereol; 1980; 60(5):456-9. PubMed ID: 6162327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flavonoids as adjuvant in psoralen based photochemotherapy in the management of vitiligo/leucoderma.
    Shivasaraun UV; Sureshkumar R; Karthika C; Puttappa N
    Med Hypotheses; 2018 Dec; 121():26-30. PubMed ID: 30396481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new psoralen-containing gel for topical PUVA therapy: development, and treatment results in patients with palmoplantar and plaque-type psoriasis, and hyperkeratotic eczema.
    De Rie MA; Van Eendenburg JP; Versnick AC; Stolk LM; Bos JD; Westerhof W
    Br J Dermatol; 1995 Jun; 132(6):964-9. PubMed ID: 7662576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psoralen and bergapten: in silico metabolism and toxicophoric analysis of drugs used to treat vitiligo.
    da Silva VB; Kawano DF; Carvalho I; da Conceição EC; de Freitas O; da Silva CH
    J Pharm Pharm Sci; 2009; 12(3):378-87. PubMed ID: 20067712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.